Virax Biolabs (VRAX) Current Assets (2021 - 2026)
Virax Biolabs (VRAX) posted quarterly Current Assets of $6.8 million for Q1 2026, up 39.54% year-over-year from $4.9 million in Q1 2025, and up 39.54% quarter-over-quarter from $4.9 million in Q1 2025.
Virax Biolabs (VRAX) Current Assets (2021 - 2026) Analysis & Trends
Virax Biolabs' Current Assets history runs 6 years deep, the most recent figure standing at $6.8 million for Q1 2026.
- In Q1 2026, Current Assets rose 39.54% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $6.8 million (up 39.54% YoY), while the FY2026 annual figure was $6.8 million, up 39.54% from the prior year.
- Current Assets for Q1 2026 stood at $6.8 million, up from $4.9 million in the prior quarter.
- The five-year high for Current Assets was $9.6 million in Q1 2023, with the low at $48706.0 in Q1 2022.
- The 5-year median for Current Assets is $4.9 million (2025), against an average of $5.2 million.
- The sharpest annual moves came in 2023 and 2024: Current Assets surged 19679.93% in 2023, then sank 54.53% in 2024.
- Virax Biolabs' Current Assets stood at $48706.0 in 2022, then soared by 19679.93% to $9.6 million in 2023, then sank by 54.53% to $4.4 million in 2024, then gained by 11.72% to $4.9 million in 2025, then soared by 39.54% to $6.8 million in 2026.
- Business Quant data shows VRAX's Current Assets at $6.8 million in Q1 2026, $4.9 million in Q1 2025, and $4.4 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | Virax Biolabs | 1.31 Mn | -5.13 Mn | - | 6.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.83 Mn |
| Mar 31, 2025 | 4.89 Mn |
| Mar 31, 2024 | 4.38 Mn |
| Mar 31, 2023 | 9.63 Mn |
| Mar 31, 2022 | 48,706.00 |
| Mar 31, 2021 | 39,621.00 |